Skip to main content
Premium Trial:

Request an Annual Quote

Cellectis Gains Access to Japan Tobacco's Genome Modification Technology

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cellectis Plant Sciences announced today a licensing agreement giving it access to Japan Tobacco's Agrobacterium transformation technology.

The technology, called PureIntro, will be used by Cellectis Plant Sciences, a subsidiary of Cellectis, to modify corn and rice genomes. Financial terms of the deal were not disclosed.

In a statement, Cellectis Plant Sciences said its technology allows for the insertion, deletion, and modification of gene sequences "to create plants expressing new traits with added value." The PureIntro technology, it added, allows for the efficient delivery of DNA to plant cells.

The technology will allow Cellectis Plant Sciences to modify corn and rice genomes using custom meganucleases.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.